Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.301\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. COc1ccc(CN=C2NN=C(c3ccccc3)CS2)cc1
b. CCCNC(=O)NCCc1ccncc1
c. Cc1cccc(C(=O)OCC(=O)N2CC(C)OC(C)C2)c1C
d. CCCNC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1
Answer: d. CCCNC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1
CCCNC(=O)C(Cc1ccccc1)NC(=O)Cc1ccccc1
3-phenyl-2-[(2-phenylacetyl)amino]-N-propylpropanamide